Multiple myeloma Clinical Trials in Lubbock, TX
As of August 2026, 3 paid clinical trials are recruiting for Multiple myeloma in Lubbock, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Lubbock
Filter results
3 clinical trials for Multiple myeloma
·Clear filters·A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Top Research Study Locations in Lubbock
Researchers run research studies in Lubbock, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UMC Cancer Center / UMC Health System | B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular, Mixed Phenotype Acute Leukemia | 17 |
| Covenant Children's Hospital | B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular, Mixed Phenotype Acute Leukemia | 16 |
| Texas Tech University Health Sciences Center | Ankle Reconstruction, Anthracycline Related Cardiotoxicity in Breast Cancer, Bioavailability | 14 |
| Texas Tech University | Burden, Caregiver, Grief, Mental Health Issue | 9 |
| GI Alliance - Lubbock | Ulcerative Colitis, Colitis, Ulcerative, Crohn Disease | 4 |
| Covenant Medical Center | Central Line Associated Blood Stream Infections (CLABSI), Intracranial Atherosclerotic Stenosis (ICAS), Malignant Neoplasm | 3 |
| Joe Arrington Cancer Research & Treatment Center | Breast Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Melanoma | 3 |
| Texas Retina Associates | Epiretinal Membrane, Proliferative Diabetic Retinopathy (PDR), Radiation Retinopathy | 3 |
| Texas Tech University Health Science Center | Amblyopia, Lupus Nephritis | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center | Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| GI Alliance | C. Diff Infection, C.Difficile Diarrhea, CDI | 2 |
| Joe Arrington Cancer Research Treatment Center | Multiple Myeloma | 2 |
| Texas Digestive Disease Consultants dba GI Alliance - Lubbock | Crohn's Disease, Ulcerative Colitis | 2 |
| Texas Tech | Acute Kidney Injury, Chronic Kidney Disease(CKD), Epidemiology | 2 |
| Texas Tech University Health Sciences Center-Lubbock | Breast Cancer, Stage I Breast Cancer | 2 |
| University Medical Center | Depression, Diabetes Mellitus, Diabetic Ketoacidosis | 2 |
| West Texas Clinical Research | Psoriatic Arthritis | 2 |
| Caprock Gastro Research | Colitis, Ulcerative, Crohn Disease, Crohn's Disease | 2 |
| Joe Arrington Cancer Research and Treatment Center | Multiple Myeloma, Diffuse Large B-Cell Lymphoma | 2 |
| Caprock Gastro Research - Lubbock | Crohn's Disease | 1 |
| Department of Kinesiology & Sport Management, Texas Tech University | Anabolic Resistance, Sarcopenia | 1 |
| GI Alliance - Bay Area Gastroenterology | Moderately to Severely Active Ulcerative Colitis | 1 |
| Garrison Institute on Aging | Mental Health Issue, Quality of Life | 1 |
| Global Aesthetics LLC | Wrinkle | 1 |
Active & Upcoming Studies in Lubbock (2026)
Recruiting trials in Lubbock grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (30 active studies)
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · Regeneron Pharmaceuticals
Diabetes & metabolic (6 active studies)
- Study of Patients Being Treated With Anti-obesity Medication · Texas Tech University
- Tirzepatide Impact Assessment Study · Texas Tech University
Neurology & pain (4 active studies)
- Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients · Phase 4 · Texas Tech University Health Sciences Center
- Ginger Root Extract for Sciatic Pain Individuals · Phase 2 · Leslie Shen
Mental health & behavior (3 active studies)
- ACT for Individuals With MNCD and Their Care Partners · Phase 1 · Texas Tech University
- Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients · Phase 4 · Texas Tech University Health Sciences Center
Cardiovascular (1 active study)
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 · Indiana University
Pediatric (1 active study)
- Speech Intervention Via Telepractice for Children With Repaired Cleft Palate · Texas Tech University Health Sciences Center
Common conditions studied in Lubbock
- Crohn's Disease (7 active studies)
- Breast Cancer (5 active studies)
- Ulcerative Colitis (5 active studies)
- Grief (3 active studies)
- Mental Health Issue (3 active studies)
- Multiple Myeloma (3 active studies)
Leading research sponsors in Lubbock
- Texas Tech University Health Sciences Center
- Texas Tech University
- Children's Oncology Group
- National Cancer Institute (NCI)
- Jaeb Center for Health Research
Frequently asked questions
How many paid clinical trials are currently recruiting in Lubbock?
There are approximately 107 recruiting clinical trials in Lubbock, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lubbock pay participants?
Most recruiting trials in Lubbock compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lubbock?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lubbock?
The most common conditions under active study in Lubbock include Crohn's Disease (7), Breast Cancer (5), Ulcerative Colitis (5), Grief (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lubbock?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lubbock on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lubbock?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lubbock?
Recruiting research sites in Lubbock include UMC Cancer Center / UMC Health System, Covenant Children's Hospital, Texas Tech University Health Sciences Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lubbock right now?
The largest active categories in Lubbock are Cancer & tumors (30), Diabetes & metabolic (6), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.